India's Generic-Drug Industry Can Take Heart With Obama Re-Election
This article was originally published in PharmAsia News
India drug makers see good news in the U.S. re-election of President Obama as an affirmation of a health-care reform plan that places an emphasis on prescriptions for generic versions of drugs, an Indian specialty.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.